哈罗健康公司（Harrow Health Inc，股票代码：HROW）今日盘前股价大涨5.13%，主要受到该公司发布的强劲季度财报推动。
根据最新公布的财务报告，哈罗健康2024年第四季度业绩显著超出市场预期。该公司报告调整后每股收益为0.24美元，远高于去年同期的-0.25美元，也大幅超过分析师平均预期的0.07美元。公司季度营收同比增长83.8%，达到6683万美元，同样超过分析师预期的6179万美元。此外，公司本季度净收入达到678万美元，展现出强劲的盈利能力。
值得注意的是，华尔街分析师对哈罗健康保持积极态度。目前，分析师对该公司股票的平均评级为"买入"，其中包括5个"强烈买入"或"买入"评级，没有"持有"、"卖出"或"强烈卖出"评级。分析师给出的12个月目标价中位数为57.00美元，显示出对公司未来发展的信心。这些积极因素共同推动了哈罗健康股价的上涨，投资者对公司的增长前景表现出乐观态度。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.